The Gene Therapy Initiative World is informing you about all the Gene Therapy activities all over the world. There are biotech companies, clinical trial companies, pharmaceutical companies, education institutions, research children’s hospitals and much more all involved in the development of this growing field.

We are in need of funding regarding research into rare neuromuscular movement disorders. If approved, we will support this research through Gene Therapy and gene editing research.

The Stephanie Cherqui gene editing lab at the University of California San Diego along with other researchers are bringing the combination of CrisprCas9 gene editing and HSC together. It is seen to be a one-time treatment leading to a cure of Friedrichs Ataxia and other diseases. This novel method and a manufacturing process has already been approved by the FDA – USA

Our growth ambitions have gone from a Foundation Gene Therapy Initiative to a startup to the development into a viable business. Our influence has reached all corners of the world. From the USA, Spain, UK, Australia, Gulf States ( Abu Dhabi ) and Argentina.

Sharing this approved Methode with a global audience is our main objective. Milliones of people affected by Friedrichs Ataxia and other neuromuscular disorders will lead the way to ridding the world of ATAXIA and neuromuscular diseases

Your sponsorship can be at the fore front of the Ataxia and neuromuscular story in Development and manufacturing.

The Solution Project Partnership Programme ‘26/27 is creating a Research , Educational and patient care opportunity for postgraduate students – focused on ATAXIA!

I, Martha Harlam , have spent a lifetime working on all aspects of ATAXIA. My experience as an educator and patient advocate for Ataxia have led me to you and Ataxia research . I invite you to visit the Solution Project website:

miracle-answer.org.   to read about my story and the work we do.

Working with you on this opportunity will give a postgraduate level student a chance to work alongside the experts at the Ataxia Center located at the Johns Hopkins University , Maryland USA , University of Chicago ( Gomez Lab for Ataxia ) the National Ataxia Foundation and the FARA Grant program USA and many others.

*As part of this 1 year scholarship experience – the Neuroaesthetics laboratory at Johns Hopkins University of the mind+art lab ( Director Susan Magsamen ) can enhance the research / education learning experience there – ATAXIA and NEUROAESTHETICS !

Please contact me to discuss how we can work together on this scholarship 1year $25,000 – $35,000 scholarship program.

Martha Harlam- Director Solution Project.       Martha.harlam@icloud.com

———————————————————————————————————————————

Affiliated Exchange Ataxia Partner Institutions, charities and Universities. ( so far )

Johns Hopkins University.                                  Goldsmith University UK

mind+art lab Susan Magsamen                         University Chicago – Gomez Ataxia

Abu Dhabi Cleveland Clinic.                               Drexel University Pennsylvania

National Ataxia Foundation.                               Florida Atlantic University

UC San Diego Gene Therapy Initiative.            Bordeaux France neurocampus

FARA / CureFA research department                City University St.George’s

Ataxia Centre Johns Hopkins USA.                   Ataxia UK research

Barcelona University Spain

Ataxia Global Initiative Germany

Queen Square Ataxia research UK London.

* A special invitation to study Ataxia gene therapy at University California at San Diego applicants are asked to discuss directly the development of the program with Stephanie Cherqui – the study/ scholarship program with her directly.

Please contact : scherqui@health.ucsd.edu